Janssen Scientific Affairs has introduced JanssenMD, a new medical information tool for accessing drug information and clinical resources through desktops, tablets, and smartphones in the US.
The new web-based application and online scientific resource is designed to enable access to current information about Janssen products marketed in the US.
Janssen Scientific Affairs chief scientific officer Dr. Norm Rosenthal said JanssenMD was created to provide healthcare professionals with the information they need, when, where, and how they need it.
"This unique digital platform enables us to respond to healthcare professionals’ questions with information that is current, accurate, and instantly accessible from any device they are using," Dr. Rosenthal added.
JanssenMD’s search functionality enables clinicians to identify full prescribing information, clinical trial data, and safety information about Janssen medications.
The company claims that it is the among the first medical information websites to offer a self-service model that is accessible through mobile devices.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataBesides product information, the web-based application provides access to Janssen prescription assistance programmes and risk evaluation and mitigation tools.
At present, JanssenMD provides scientific information for five pharmaceutical products Edurant (rilpivirine), Remicade (infliximab), Stelara (ustekinumab), Xarelto (rivaroxaban), and Zytiga (abiraterone acetate); additional Janssen products will be added over time.